For patients with a rare genetic disorder that turns their muscles into bone, there is new hope. The disease is called fibrodysplasia ossificans progressiva (FOP), or "stone man syndrome." It ...
The Independent Data Monitoring Committee recommended transitioning patients in the placebo arm to garetosmab as soon as possible. Topline data were announced from a phase 3 trial evaluating ...
PARIS, FRANCE, 19 December 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the pivotal Phase II FALKON trial did not meet its primary endpoint of reducing new heterotopic ossification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results